Literature DB >> 23474491

icb-1 Gene counteracts growth of ovarian cancer cell lines.

Oliver Treeck1, Susanne Schüler, Julia Häring, Maciej Skrzypczak, Claus Lattrich, Olaf Ortmann.   

Abstract

Human gene icb-1 has been originally identified to be involved in differentiation processes of cancer cells. To examine the function of icb-1 in ovarian cancer, we knocked down its expression in three ovarian cancer cell lines and performed microarray-based gene expression profiling with subsequent gene network modeling. Loss of icb-1 expression accelerated proliferation of SK-OV-3, OVCAR-3 and OAW-42 cells and led to upregulation of ovarian cancer biomarkers like KLK10 and CLDN16. Most of the upregulated genes were part of oncogenic pathways regulated by ERα or TNF. Our data suggest that icb-1 gene inhibits growth and progression of ovarian cancer cells.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474491     DOI: 10.1016/j.canlet.2013.02.049

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Icb-1 expression inhibits growth and fulvestrant response of breast cancer cells and affects survival of breast cancer patients.

Authors:  Maria Riedmeier; Maciej Skrzypczak; Susanne Schüler-Toprak; Olaf Ortmann; Oliver Treeck
Journal:  Arch Gynecol Obstet       Date:  2021-01-03       Impact factor: 2.344

2.  Splice variants of zinc finger protein 695 mRNA associated to ovarian cancer.

Authors:  Sergio Juárez-Méndez; Alejandro Zentella-Dehesa; Vanessa Villegas-Ruíz; Oscar Alberto Pérez-González; Mauricio Salcedo; Ricardo López-Romero; Edgar Román-Basaure; Minerva Lazos-Ochoa; Víctor Edén Montes de Oca-Fuentes; Guelaguetza Vázquez-Ortiz; José Moreno
Journal:  J Ovarian Res       Date:  2013-09-05       Impact factor: 4.234

3.  Icb-1 gene polymorphism rs1467465 is associated with susceptibility to ovarian cancer.

Authors:  Susanne Schüler; Claus Lattrich; Maciej Skrzypczak; Tanja Fehm; Olaf Ortmann; Oliver Treeck
Journal:  J Ovarian Res       Date:  2014-04-23       Impact factor: 4.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.